✦ LIBER ✦

A pooled analysis of injection site-related adverse events in patients with schizophrenia treated with olanzapine long-acting injection

✍ Scribed by Atkins, Susan; Detke, Holland C; McDonnell, David P; Case, Michael G; Wang, Shufang

Book ID: 121567280
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 163 KB
Volume: 14
Category: Article
ISSN: 1471-244X
DOI: 10.1186/1471-244X-14-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Schizophrenia symptoms and functioning i

Schizophrenia symptoms and functioning in patients receiving long-term treatment with olanzapine long-acting injection formulation: a pooled analysis

✍ Joseph Peuskens, Vibeke Porsdal, Jan Pecenak, Peter Handest… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 212 KB

26 – Remission in patients with schizoph

26 – Remission in patients with schizophrenia treated with risperidone long-acting injection (RLAI)

✍ J. Peuskens; M. Povey; J. Van Der Veken; A. Jacobs 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 79 KB

PMH42 COST-EFFECTIVENESS ANALYSIS OF OLA

PMH42 COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE LONG-ACTING INJECTION COMPARED WITH RISPERIDONE LONG-ACTING INJECTION IN THE TREATMENT OF SCHIZOPHRENIA IN NORWAY

✍ SM Carroll; N Jemiai; B Suter; P O'Donohoe; U Skjoldborg; J Moller; OK Kleivenes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Comparison of metabolic changes in patie

Comparison of metabolic changes in patients with schizophrenia during randomized treatment with intramuscular olanzapine long-acting injection versus oral olanzapine

✍ David P. McDonnell; Ludmila A. Kryzhanovskaya; Fangyi Zhao; Holland C. Detke; Pe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 1 views

Metabolic changes were examined in patients with schizophrenia during treatment with either oral olanzapine or olanzapine long‐acting injection (LAI). Data were collected from patients who had been stabilized on oral olanzapine (10, 15, or 20 mg/day) for ≥4 weeks and then randomized to either contin

P03-25 Risperidone long-acting injectabl

P03-25 Risperidone long-acting injectable in stable patients with schizophrenia or related disorders switched from oral olanzapine

✍ Rosa, F.; Thomas, P.; Schreiner, A.; Sherif, T. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 French ⚖ 45 KB

Clinical and functional outcomes of pati

Clinical and functional outcomes of patients with schizophrenia treated with risperidone long-acting injection versus oral antipsychotics

✍ J.M. Olivares; A. Rodriguez Morales; J. Diels; M. Povey; A. Lam; Z. Zhao 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 62 KB